Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pralatrexate in Relapsed/Refractory PTCL
NCT00364923Phase 2Completed
- Sponsor
- Acrotech Biopharma Inc
- Start
- Aug 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, open-label, single-arm trial of pralatrexate in peripheral T-cell lymphoma (PTCL), sponsored by Acrotech Biopharma Inc. Primary endpoint: Response Rate Per Independent Central Review up to 2 years. Started Aug 2006; status: completed.
02
Drugs
pralatrexate
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00364923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364923.